eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Head & Neck Surgery
Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma: Workup
Updated: May 22, 2008
Workup
Imaging Studies
- Contrast-enhanced CT scanning helpful for determining the extent of tumor infiltration. Detection of grossly positive nodal disease, particularly when central necrosis is present, is enhanced with contrast-enhanced CT scans. The accuracy for detecting nodal metastases is reportedly improved from 70% to 93% when a physical examination is combined with CT scans, but occult disease can still be missed.
- Fluorodeoxyglucose-positron emission tomography is performed before removal of the primary tumor and/or dissection of the neck, and results are compared with those from histopathology studies. Fluorodeoxyglucose-positron emission tomography confirms the clinically identified location of the primary tumor site. Fluorodeoxyglucose-positron emission tomography shows promise in the initial staging of cancer of the head and the neck. It also provides additional accuracy to the conventional staging process using CT scans.
- MRI is beneficial for staging the size of the suggestive lymph nodes, for the evaluation of central lucency reflecting necrosis, for the assessment of irregular nodes with rim enhancement, for the evaluation of indistinct nodal margins, and for obliteration of fat or tissue planes.
Other Tests
Imaging studies are performed to detect any lymph node metastases. If the imaging studies fail to positively show lymph node metastases, a SLN biopsy is indicated for oral and oropharyngeal SCCs.
Histologic Findings
The current histopathologic routine is to step-section the SLNs at multiple levels and to perform immunohistochemical staining with S-100 protein and homatropine methylbromide to identify micrometastatic disease. If any question remains about abnormal cells after the first sections are taken, additional sections are obtained. Immunohistochemistry results identify an additional 10-20% of patients with positive SLNs, in whom micrometastases are not seen on routine sections stained with permanent hematoxylin and eosin (H&E). At least some of the increased rate of detection of micrometastatic disease is attributable to step-sectioning at multiple levels.
The approach for sampling involves bivalving the lymph node, fixing the 2 halves face down, and subsequently sectioning each half into 10 sections, which are alternately used for H&E staining, immunohistochemistry testing, and molecular staging. The sensitivity of intraoperative frozen section examination of the SLN is disappointingly low (<50%), although false-positive results are almost never reported. Because of concerns about tissue loss during the frozen section procedure, most centers eschew frozen sections and rely on permanent sections, except to confirm grossly suggestive metastatic disease.
Staging
Lymph node groups of the neck region are divided into 2 triangles, the anterior and the posterior triangles, which are further subdivided as follows:
- The anterior triangle of the neck is bounded (1) anteriorly by the median plane, (2) posteriorly by the sternocleidomastoid muscle, and (3) superiorly by the base of the mandible. Also, a line joins the angle of the mandible to the mastoid process. The apex of the triangle lies above the manubrium sterni. The anterior triangle is subdivided by the digastric muscle and the superior belly of the omohyoid into the submental triangle, the digastric triangle, the carotid triangle, and the muscular triangle.
- The submental triangle is the median triangle. On each side, the boundaries are the anterior belly of the corresponding digastric muscles. Its base is formed by the body of the hyoid bone. Its apex lies at the chin. The floor of the triangle is formed by the right and left mylohyoid muscles, with the median raphe uniting them.
- The digastric triangle boundaries are, anteroinferiorly, the anterior belly of the digastric; posteroinferiorly, the posterior belly of the digastric and the stylohyoid; and superiorly (base), the base of the mandible and a line joining the angle of the mandible to the mastoid process. The roof boundary is the skin, superficial fascia, and deep fascia. The floor is formed by the mylohyoid muscle anteriorly and by the hyoglossus posteriorly and anteroinferiorly.
- The carotid triangle boundaries are, superiorly, the posterior belly of the digastric muscle and the stylohyoid; anteroinferiorly, the superior belly of the omohyoid; and posteriorly, the anterior border of the sternocleidomastoid muscle. The roof boundary is skin, superficial fascia, and an investing layer of deep fascia. The floor is formed by parts of the thyrohyoid muscle, the hyoglossus, and the middle and inferior constrictors of the pharynx. Most of the SLNs are found in the carotid or the digastric triangle.
- The muscular triangle includes the superficial structures in the infrahyoid region. The boundaries are, anteriorly, the anterior median line of the neck from the hyoid bone to the sternum; posterosuperiorly, the superior belly of the omohyoid muscle; and posteroinferiorly, the anterior border of the sternocleidal mastoid muscle.
- The posterior triangle is a space on the side of the neck situated behind the sternocleidomastoid muscle. The boundaries are, (1) anteriorly, the posterior border of the sternocleidomastoid muscle; (2) posteriorly, the anterior body of the trapezius; and (3) inferiorly (base), the middle third of the clavicle. The apex lies on the superior nuchal line where the trapezius and sternocleidomastoid muscle meet. The posterior triangle is subdivided by the inferior belly of the omohyoid into the omohyoid triangle and the supraclavicular triangle. Lymph node dissection in both the triangles in the posterior compartment is considered to be the same level.
More on Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma |
| Overview: Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma |
Workup: Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma |
| Treatment: Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma |
| Follow-up: Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma |
| References |
| « Previous Page | Next Page » |
References
Alex JC, Weaver DL, Fairbank JT, et al. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol. Oct 1993;2(5):303-8. [Medline].
Koch WM, Choti MA, Civelek AC, et al. Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. Apr 1998;124(4):455-9. [Medline].
Pitman KT, Johnson JT, Edington H, et al. Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. Jul 1998;124(7):790-3. [Medline].
Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am. Jan 1996;5(1):33-41. [Medline].
Alex JC, Sasaki CT, Krag DN, et al. Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma. Laryngoscope. Feb 2000;110(2 Pt 1):198-203. [Medline].
Asthana S, Deo SV, Shukla NK. Intraoperative neck staging using sentinel node biopsy and imprint cytology in oral cancer. Head Neck. May 2003;25(5):368-72. [Medline].
Civantos FJ, Gomez C, Duque C. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck. Jan 2003;25(1):1-9. [Medline].
Cochran AJ, Wen DR, Farzad Z, et al. Immunosuppression by melanoma cells as a factor in the generation of metastatic disease. Anticancer Res. Jul-Aug 1989;9(4):859-64. [Medline].
Hughes CJ, Gallo O, Spiro RH, Shah JP. Management of occult neck metastases in oral cavity squamous carcinoma. Am J Surg. Oct 1993;166(4):380-3. [Medline].
Kontio R, Leivo I, Leppänen E. Sentinel lymph node biopsy in oral cavity squamous cell carcinoma without clinically evident metastasis. Head Neck. Jan 2004;26(1):16-21. [Medline].
Kovács AF. Head and neck squamous cell carcinoma: sentinel node or selective neck dissection. Surg Oncol Clin N Am. Jan 2007;16(1):81-100. [Medline].
Martinez JC, Cook JL. High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection?. Dermatol Surg. Apr 2007;33(4):410-20. [Medline].
Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. Apr 1992;127(4):392-9. [Medline].
Pillsbury HC 3rd, Clark M. A rationale for therapy of the N0 neck. Laryngoscope. Oct 1997;107(10):1294-315. [Medline].
Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. Dec 1994;220(6):759-67. [Medline].
Ross GL, Shoaib T, Scott J, et al. The learning curve for sentinel node biopsy in malignant melanoma. Br J Plast Surg. Jun 2002;55(4):298-301. [Medline].
Ross GL, Shoaib T, Soutar DS, et al. The First International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer and adoption of a multicenter trial protocol. Ann Surg Oncol. May 2002;9(4):406-10. [Medline].
Shah JP, Andersen PE. Evolving role of modifications in neck dissection for oral squamous carcinoma. Br J Oral Maxillofac Surg. Feb 1995;33(1):3-8. [Medline].
Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer. Jun 1 2001;91(11):2077-83. [Medline].
Werner JA, Dünne AA, Ramaswamy A, Dalchow C, Behr T, Moll R, et al. The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck?. Head Neck. Jul 2004;26(7):603-11. [Medline].
Woolgar JA, Vaughan ED, Scott J, Brown JS. Pathological findings in clinically false-negative and false-positive neck dissections for oral carcinoma. Ann R Coll Surg Engl. Jul 1994;76(4):237-44. [Medline].
Further Reading
Keywords
sentinel lymph node biopsy in patients with squamous cell carcinoma, sentinel node, SN, SLN, SLN biopsy, SLN mapping, sentinel lymph node mapping, skin malignancy, skin cancer, skin squamous cell cancer, squamous cell skin cancer, skin cancer diagnosis, skin SCC, squamous cell carcinoma, SCC, squamous skin cancer, SC cancer, cutaneous SCC, cutaneous squamous cell carcinoma, sun exposure, lymph node disease, lymph node cancer, head and neck SCC, head and neck cancer, head and neck carcinoma, head and neck malignancy, head and neck squamous cell carcinoma, lymph node dissection
Workup: Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma